Sending, Baby Boy .

HRN: 28-66-97  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2026
AMPICILLIN 250MG (VIAL)
03/07/2026
03/14/2026
IVTT
65mg
Q12h
PSNB; Prematurity
Remove - Pending Acceptance
03/07/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
03/07/2026
03/14/2026
IVTT
6.5mg
Q24h
PSNB; Prematurity
Remove - Pending Acceptance
03/13/2026
CEFOTAXIME 500MG (VIAL)
03/13/2026
03/20/2026
IV DRIP
65mg
Q12
Neonatal Sepsis
Checking Initial Appropriateness 
03/23/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/23/2026
03/30/2026
IV
16mg As LD X1 Then 8mg IVTT As MD
Q24
Neonatal Sepsis
Remove - Pending Acceptance
03/23/2026
CEFTAZIDIME 1GM (VIAL)
03/23/2026
03/30/2026
IV
40mg
Q8
Neonatal Sepsis
Remove - Pending Acceptance
03/23/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2026
03/30/2026
IV
16mg
Q24
NEONATAL SEPSIS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: